Evaluation of CD38 expression in Sudanese patients with chronic lymphocytic leukemia

• Published in: BMC research notes 2018-11, Vol.11 (1), p.815-815, Article 815
• Main Authors: Abdelgader, Enaam Abdelrhman, Eltayeb, Nada Hassan, Eltahir, Tasniem Ahmed, Altayeb, Osama Ali, Fadul, Eman Abbass, Abdel Rahman, Eldirdiri M, Merghani, Tarig H
• Format: Article
• Language: English
• Subjects: ADP-ribosyl Cyclase 1 - metabolism; Adult; Aged; Aged, 80 and over; Agent Orange; Cancer; CD38; CD38 antigen; Cell adhesion & migration; Chronic lymphocytic leukemia; CLL; Cross-Sectional Studies; Data processing; Female; Flow Cytometry - methods; Flowcytometer; Hematology; Hemoglobin; Humans; Immunoglobulins; Immunophenotyping - methods; Kinases; Laboratories; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis; Leukemia, Lymphocytic, Chronic, B-Cell - metabolism; Lymphatic leukemia; Male; Medical prognosis; Membrane Glycoproteins - metabolism; Middle Aged; Mutation; Oncology; Patients; Prognosis; Research Note; Signal transduction; Studies; Sudan
• ISSN: 1756-0500; 1756-0500
• DOI: 10.1186/s13104-018-3926-0

The objective of this study was to evaluate the cluster of differentiation-38 (CD38) expression in Sudanese patients with chronic lymphocytic leukemia (CLL) and to determine its association with clinical and laboratory characteristics of the disease. We conducted a cross-sectional study on 99 patients diagnosed with CLL in Khartoum Oncology Hospital in Khartoum, Sudan. Immunophenotyping and CD38 expression levels were measured with four-color flowcytometry. The results of physical examination and blood analyses were used for assigning a modified Rai clinical staging system. The collected data were analyzed using the Statistical Package for the Social Science, version 22 (SPSS Inc., Chicago, IL, USA). According to our findings, the frequencies of 7%, 20%, and 30% cutoff levels of CD38 expressions were 68.7%, 41.4%, and 36.4% respectively. CD38 cutoff level of 7% showed a significant association with hemoglobin concentration (P = 0.04), whereas other cutoff levels showed insignificant results. All the three cutoff levels showed insignificant associations with the other clinical and laboratory variables. In conclusion, the CD38 expression at a cutoff level of 7% seems to be more valuable clinically than higher cutoff levels in Sudanese CLL patients.